SARAH BROWNING: Open Payments
NPI 1720442197 · DRIPPING SPRINGS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,604 in 83 payments from 15 companies in 2025. Trend: 2023 $1,507 · 2024 $1,612 · 2025 $1,604
Food & beverage: $1,604
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $265 |
| PFIZER INC. | 11 | $204 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $190 |
| AstraZeneca Pharmaceuticals LP | 7 | $186 |
| GlaxoSmithKline, LLC. | 11 | $183 |
| Bausch Health US, LLC | 7 | $131 |
| Lilly USA, LLC | 8 | $119 |
| Novo Nordisk Inc | 5 | $107 |
| Abbott Laboratories | 2 | $66 |
| Exact Sciences Corporation | 2 | $40 |
Products named: JARDIANCE, TRELEGY ELLIPTA, APLENZIN, UBRELVY, MOUNJARO, FARXIGA, ELIQUIS, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
